These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27888799)

  • 1. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
    Palanichamy K; Sreejayan N; Ontko AC
    J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
    Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
    Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
    Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
    Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.
    Bhatt M; Ivan C; Xie X; Siddik ZH
    Oncotarget; 2017 Feb; 8(7):10905-10918. PubMed ID: 28038466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
    Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.
    Nardon C; Schmitt SM; Yang H; Zuo J; Fregona D; Dou QP
    PLoS One; 2014; 9(1):e84248. PubMed ID: 24392119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.
    Altaf M; Casagrande N; Mariotto E; Baig N; Kawde AN; Corona G; Larcher R; Borghese C; Pavan C; Seliman AA; Aldinucci D; Isab AA
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30987271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer.
    Geng YD; Zhang C; Lei JL; Yu P; Xia YZ; Zhang H; Yang L; Kong LY
    Biochem Pharmacol; 2017 Oct; 142():71-86. PubMed ID: 28673807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.
    Bertrand B; Spreckelmeyer S; Bodio E; Cocco F; Picquet M; Richard P; Le Gendre P; Orvig C; Cinellu MA; Casini A
    Dalton Trans; 2015 Jul; 44(26):11911-8. PubMed ID: 26060937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
    J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.